Nicotinamide Riboside (NIAGEN)
NAD+ precursor (most-studied form)
Nicotinamide Riboside: NAD+ precursor (most-studied form). The most clinically-studied NAD+ precursor. Patented NIAGEN form has 20+ published human trials. Standard dose 300 mg, taken in the morning, about $45/month. Evidence rating: strong evidence.
What is Nicotinamide Riboside?
Nicotinamide riboside (NR) is a form of vitamin B3 and a precursor to NAD+. The NIAGEN form, made by ChromaDex, is the most clinically-studied NAD+ booster on the market with over 20 published human trials demonstrating safe and significant elevation of blood NAD+ levels at doses of 100-1000 mg/day. NR has shown benefits for cellular energy, exercise tolerance in older adults, and metabolic markers. Unlike NMN, NIAGEN is GRAS-affirmed by the FDA and NDI-approved as a dietary supplement. Standard daily dose is 300 mg in the morning.
The most clinically-studied NAD+ precursor. Patented NIAGEN form has 20+ published human trials.
Where to buy
suppdoc.io is an affiliate. Links may earn us a commission at no extra cost to you.
Common questions
Not sure if Nicotinamide Riboside is right for you?
Take our quiz. We'll compose a personalised stack that fits your goals, body, and budget, in minutes.
Take the quiz →